annual CFF:
$1.19B+$4.54B(+135.62%)Summary
- As of today (May 21, 2025), ELV annual cash flow from financing activities is $1.19 billion, with the most recent change of +$4.54 billion (+135.62%) on December 31, 2024.
- During the last 3 years, ELV annual CFF has risen by +$770.00 million (+182.03%).
- ELV annual CFF is now -51.24% below its all-time high of $2.45 billion, reached on December 31, 2005.
Performance
ELV Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$1.91B-$3.32B(-235.58%)Summary
- As of today (May 21, 2025), ELV quarterly cash flow from financing activities is -$1.91 billion, with the most recent change of -$3.32 billion (-235.58%) on March 31, 2025.
- Over the past year, ELV quarterly CFF has dropped by -$1.94 billion (-6065.62%).
- ELV quarterly CFF is now -156.35% below its all-time high of $3.39 billion, reached on March 31, 2021.
Performance
ELV quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$748.00M-$1.94B(-162.70%)Summary
- As of today (May 21, 2025), ELV TTM cash flow from financing activities is -$748.00 million, with the most recent change of -$1.94 billion (-162.70%) on March 31, 2025.
- Over the past year, ELV TTM CFF has increased by +$2.04 billion (+73.15%).
- ELV TTM CFF is now -127.94% below its all-time high of $2.68 billion, reached on March 31, 2013.
Performance
ELV TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ELV Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +135.6% | -6065.6% | +73.2% |
| 3 y3 years | +182.0% | -692.9% | +71.7% |
| 5 y5 years | +152.7% | -381.1% | +35.4% |
ELV Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +135.6% | -235.6% | at low | -162.7% | +78.5% |
| 5 y | 5-year | at high | +135.6% | -156.3% | +19.4% | -162.7% | +78.5% |
| alltime | all time | -51.2% | +131.9% | -156.3% | +19.4% | -127.9% | +86.0% |
ELV Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$1.91B(-235.6%) | -$748.00M(-162.7%) |
| Dec 2024 | $1.19B(-135.6%) | $1.41B(-253.9%) | $1.19B(-295.9%) |
| Sep 2024 | - | -$915.00M(-237.0%) | -$609.00M(-11.5%) |
| Jun 2024 | - | $668.00M(+1987.5%) | -$688.00M(-75.3%) |
| Mar 2024 | - | $32.00M(-108.1%) | -$2.79B(-16.8%) |
| Dec 2023 | -$3.35B(+154.1%) | -$394.00M(-60.4%) | -$3.35B(+4.2%) |
| Sep 2023 | - | -$994.00M(-30.5%) | -$3.21B(-7.5%) |
| Jun 2023 | - | -$1.43B(+169.3%) | -$3.47B(+60.0%) |
| Mar 2023 | - | -$531.00M(+105.8%) | -$2.17B(+64.7%) |
| Dec 2022 | -$1.32B(-411.6%) | -$258.00M(-79.4%) | -$1.32B(-44.5%) |
| Sep 2022 | - | -$1.25B(+888.2%) | -$2.38B(+21.8%) |
| Jun 2022 | - | -$127.00M(-139.4%) | -$1.95B(-26.2%) |
| Mar 2022 | - | $322.00M(-124.5%) | -$2.64B(-724.8%) |
| Dec 2021 | $423.00M(-116.5%) | -$1.31B(+58.4%) | $423.00M(-167.2%) |
| Sep 2021 | - | -$830.00M(+1.2%) | -$629.00M(-19.7%) |
| Jun 2021 | - | -$820.00M(-124.2%) | -$783.00M(-651.4%) |
| Mar 2021 | - | $3.39B(-243.1%) | $142.00M(-105.5%) |
| Dec 2020 | -$2.57B(+13.3%) | -$2.37B(+140.5%) | -$2.57B(+70.7%) |
| Sep 2020 | - | -$984.00M(-1037.1%) | -$1.50B(+300.0%) |
| Jun 2020 | - | $105.00M(-84.5%) | -$376.00M(-67.5%) |
| Mar 2020 | - | $679.00M(-152.1%) | -$1.16B(-48.9%) |
| Dec 2019 | -$2.27B(+1.1%) | -$1.30B(-1005.6%) | -$2.27B(-10.2%) |
| Sep 2019 | - | $144.00M(-121.3%) | -$2.52B(-16.1%) |
| Jun 2019 | - | -$677.00M(+57.8%) | -$3.01B(+47.2%) |
| Mar 2019 | - | -$429.00M(-72.5%) | -$2.04B(-8.8%) |
| Dec 2018 | -$2.24B(-624.8%) | -$1.56B(+359.1%) | -$2.24B(-227.8%) |
| Sep 2018 | - | -$340.00M(-218.5%) | $1.75B(+320.9%) |
| Jun 2018 | - | $287.00M(-145.8%) | $416.50M(-129.0%) |
| Mar 2018 | - | -$627.00M(-125.8%) | -$1.43B(-435.9%) |
| Dec 2017 | $427.00M(-153.4%) | $2.43B(-245.1%) | $427.00M(-129.9%) |
| Sep 2017 | - | -$1.68B(+7.2%) | -$1.43B(+418.7%) |
| Jun 2017 | - | -$1.56B(-226.7%) | -$275.10M(-132.6%) |
| Mar 2017 | - | $1.23B(+113.2%) | $844.00M(-205.6%) |
| Dec 2016 | -$799.00M(-74.2%) | $579.00M(-210.4%) | -$799.00M(-67.9%) |
| Sep 2016 | - | -$524.60M(+18.0%) | -$2.49B(-2.7%) |
| Jun 2016 | - | -$444.70M(+8.8%) | -$2.56B(-33.0%) |
| Mar 2016 | - | -$408.70M(-63.1%) | -$3.81B(+23.3%) |
| Dec 2015 | -$3.09B(+69.7%) | -$1.11B(+86.6%) | -$3.09B(+23.0%) |
| Sep 2015 | - | -$593.90M(-65.1%) | -$2.51B(+1.3%) |
| Jun 2015 | - | -$1.70B(-646.0%) | -$2.48B(+98.2%) |
| Mar 2015 | - | $311.90M(-159.0%) | -$1.25B(-31.3%) |
| Dec 2014 | -$1.82B(+6.1%) | -$528.90M(-5.7%) | -$1.82B(-9.8%) |
| Sep 2014 | - | -$560.90M(+18.3%) | -$2.02B(+1.2%) |
| Jun 2014 | - | -$474.10M(+83.3%) | -$2.00B(+42.8%) |
| Mar 2014 | - | -$258.60M(-64.4%) | -$1.40B(-18.7%) |
| Dec 2013 | -$1.72B | -$725.80M(+35.2%) | -$1.72B(+286.7%) |
| Sep 2013 | - | -$536.80M(-533.3%) | -$444.20M(-126.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | $123.90M(-121.4%) | $1.66B(-38.0%) |
| Mar 2013 | - | -$579.10M(-205.7%) | $2.68B(+28.1%) |
| Dec 2012 | $2.09B(-203.5%) | $547.80M(-65.0%) | $2.09B(+162.1%) |
| Sep 2012 | - | $1.57B(+37.2%) | $797.10M(-249.0%) |
| Jun 2012 | - | $1.14B(-197.8%) | -$535.10M(-77.7%) |
| Mar 2012 | - | -$1.17B(+56.9%) | -$2.40B(+18.9%) |
| Dec 2011 | -$2.02B(-36.3%) | -$744.00M(-417.8%) | -$2.02B(-8.8%) |
| Sep 2011 | - | $234.10M(-132.4%) | -$2.21B(-2.9%) |
| Jun 2011 | - | -$723.50M(-7.9%) | -$2.28B(-18.4%) |
| Mar 2011 | - | -$785.80M(-16.4%) | -$2.80B(-11.7%) |
| Dec 2010 | -$3.17B(-6.9%) | -$939.80M(-661.1%) | -$3.17B(-7.9%) |
| Sep 2010 | - | $167.50M(-113.5%) | -$3.44B(-27.3%) |
| Jun 2010 | - | -$1.24B(+7.0%) | -$4.73B(+8.6%) |
| Mar 2010 | - | -$1.16B(-4.3%) | -$4.35B(+27.9%) |
| Dec 2009 | -$3.40B(-8.9%) | -$1.21B(+7.9%) | -$3.40B(+16.2%) |
| Sep 2009 | - | -$1.12B(+29.7%) | -$2.93B(+8.1%) |
| Jun 2009 | - | -$864.30M(+317.7%) | -$2.71B(+21.3%) |
| Mar 2009 | - | -$206.90M(-71.9%) | -$2.24B(-40.2%) |
| Dec 2008 | -$3.74B(+9.6%) | -$736.70M(-18.4%) | -$3.74B(-16.6%) |
| Sep 2008 | - | -$902.50M(+131.9%) | -$4.48B(-15.9%) |
| Jun 2008 | - | -$389.20M(-77.2%) | -$5.32B(+15.8%) |
| Mar 2008 | - | -$1.71B(+15.3%) | -$4.60B(+34.8%) |
| Dec 2007 | -$3.41B(-8.5%) | -$1.48B(-15.3%) | -$3.41B(+26.6%) |
| Sep 2007 | - | -$1.75B(-617.9%) | -$2.69B(+247.1%) |
| Jun 2007 | - | $337.60M(-165.0%) | -$775.70M(-68.5%) |
| Mar 2007 | - | -$519.00M(-32.0%) | -$2.46B(-34.0%) |
| Dec 2006 | -$3.73B(-252.3%) | -$762.70M(-552.9%) | -$3.73B(+338.5%) |
| Sep 2006 | - | $168.40M(-112.5%) | -$849.50M(+23.7%) |
| Jun 2006 | - | -$1.35B(-24.6%) | -$686.70M(-229.4%) |
| Mar 2006 | - | -$1.79B(-184.5%) | $530.70M(-78.3%) |
| Dec 2005 | $2.45B(+18.6%) | $2.11B(+537.9%) | $2.45B(+1.2%) |
| Sep 2005 | - | $331.20M(-358.3%) | $2.42B(+19.4%) |
| Jun 2005 | - | -$128.20M(-198.1%) | $2.02B(-6.5%) |
| Mar 2005 | - | $130.70M(-93.7%) | $2.16B(+4.9%) |
| Dec 2004 | $2.06B(-893.0%) | $2.08B(-3453.9%) | $2.06B(-2915.0%) |
| Sep 2004 | - | -$62.10M(-596.8%) | -$73.30M(-48.1%) |
| Jun 2004 | - | $12.50M(-58.6%) | -$141.20M(-6.9%) |
| Mar 2004 | - | $30.20M(-156.0%) | -$151.60M(-41.7%) |
| Dec 2003 | -$260.20M(-136.7%) | -$53.90M(-58.5%) | -$260.20M(-23.4%) |
| Sep 2003 | - | -$130.00M(-6290.5%) | -$339.50M(-150.6%) |
| Jun 2003 | - | $2.10M(-102.7%) | $670.30M(+6.3%) |
| Mar 2003 | - | -$78.40M(-41.1%) | $630.80M(-11.1%) |
| Dec 2002 | $709.30M(+1422.1%) | -$133.20M(-115.1%) | $709.30M(-15.8%) |
| Sep 2002 | - | $879.80M(-2452.4%) | $842.50M(-2358.7%) |
| Jun 2002 | - | -$37.40M(<-9900.0%) | -$37.30M(<-9900.0%) |
| Mar 2002 | - | $100.00K | $100.00K |
| Dec 2001 | $46.60M | - | - |
FAQ
- What is Elevance Health annual cash flow from financing activities?
- What is the all time high annual CFF for Elevance Health?
- What is Elevance Health annual CFF year-on-year change?
- What is Elevance Health quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Elevance Health?
- What is Elevance Health quarterly CFF year-on-year change?
- What is Elevance Health TTM cash flow from financing activities?
- What is the all time high TTM CFF for Elevance Health?
- What is Elevance Health TTM CFF year-on-year change?
What is Elevance Health annual cash flow from financing activities?
The current annual CFF of ELV is $1.19B
What is the all time high annual CFF for Elevance Health?
Elevance Health all-time high annual cash flow from financing activities is $2.45B
What is Elevance Health annual CFF year-on-year change?
Over the past year, ELV annual cash flow from financing activities has changed by +$4.54B (+135.62%)
What is Elevance Health quarterly cash flow from financing activities?
The current quarterly CFF of ELV is -$1.91B
What is the all time high quarterly CFF for Elevance Health?
Elevance Health all-time high quarterly cash flow from financing activities is $3.39B
What is Elevance Health quarterly CFF year-on-year change?
Over the past year, ELV quarterly cash flow from financing activities has changed by -$1.94B (-6065.62%)
What is Elevance Health TTM cash flow from financing activities?
The current TTM CFF of ELV is -$748.00M
What is the all time high TTM CFF for Elevance Health?
Elevance Health all-time high TTM cash flow from financing activities is $2.68B
What is Elevance Health TTM CFF year-on-year change?
Over the past year, ELV TTM cash flow from financing activities has changed by +$2.04B (+73.15%)